Intellia Therapeutics
NTLA
NTLA
141 hedge funds and large institutions have $430M invested in Intellia Therapeutics in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
42% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 36
48% less capital invested
Capital invested by funds: $833M → $430M (-$403M)
Holders
141
Holding in Top 10
3
Calls
$2.21M
Puts
$1.43M
Top Buyers
| 1 | +$22.7M | |
| 2 | +$14.3M | |
| 3 | +$3.58M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.38M |
| 5 |
Renaissance Technologies
New York
|
+$3.11M |
Top Sellers
| 1 | -$15.7M | |
| 2 | -$5.01M | |
| 3 | -$4.07M | |
| 4 |
GAM
Greenwoods Asset Management
Grand Cayman,
Cayman Islands
|
-$3.66M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$3.63M |